Friday, December 19, 2014 1:05:58 PM
it makes no sense for Hensley as Itonis Pharma to be doing what he could be doing under Migranade for emesyl where he owns the whole 9 yards. If he has more irons in the fire product wise he has 2 choices of companies in which to pursue that, but I figure with Oasis being his lab I think Migranade would be the preference, which does not help ITNS at all.
right now, Itonis (non-pharma) has only what comes under myec, which for the moment is zilch
so I feel that the situation between Cheung and Hensley is still very vague, in dealing with a product common to two companies in some way
Cheung does not "own" Hensley and whatever he does
it is way over my head
Are we rich yet?
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM